Clinical Trials on 继发于结缔组织病的雷诺现象 in China
总计3717个结果
-
Shanghai Children's Medical Center尚未招聘
-
First Affiliated Hospital of Chengdu Medical College招聘中
-
Peking University People's HospitalPeking University; Northwestern University未知对 Famitinib 和 Camrelizumab 的耐药性 | 疗效和毒性的生物标志物中国
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.招聘中
-
Zhejiang Hisun Pharmaceutical Co. Ltd.完全的
-
Kunming Medical UniversityChinese Academy of Sciences完全的
-
Peking University People's HospitalPeking University Shougang Hospital完全的
-
First Affiliated Hospital Xi'an Jiaotong University招聘中
-
Chengdu Kanghong Biotech Co., Ltd.未知
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin China Pharmaceutical Co., LTD.撤销
-
Tianjin Medical University Cancer Institute and...未知
-
Chengdu Kanghong Biotech Co., Ltd.未知Choroid Neovascularization Secondary to Degenerative Myopia中国
-
Hoffmann-La Roche招聘中继发于病理性近视的脉络膜新生血管大韩民国, 中国, 澳大利亚, 新加坡, 波兰, 法国, 德国, 意大利, 台湾, 香港
-
Shanghai Jiao Tong University School of MedicineWest China Hospital; Guangzhou General Hospital of Guangzhou Military Command; Second Affiliated... 和其他合作者未知
-
Novartis Pharmaceuticals完全的继发于病理性近视 (PM) 的脉络膜新生血管 (CNV) 导致的视力障碍中国, 印度, 泰国, 香港, 大韩民国, 菲律宾
-
UCB Biopharma SRL主动,不招人
-
Peking University First HospitalPeking University Cancer Hospital & Institute终止
-
Shanghai Hengrui Pharmaceutical Co., Ltd.邀请报名
-
Novartis Pharmaceuticals完全的
-
RenJi HospitalThe First Affiliated Hospital with Nanjing Medical University; The First Affiliated Hospital... 和其他合作者招聘中
-
Peking University People's Hospital未知